Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Hoff, A. L. Articles by Nordahl, T. E. Search for Related Content PubMed Citation Articles by Hoff, A. L. Articles by Nordahl, T. E. Neuropsychology Gender Schizophrenia Spectrum Disorders Cognition

Association of Estrogen Levels With Neuropsychological Performance in Women With Schizophrenia

OBJECTIVE: This study sought to determine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in female patients with schizophrenia. METHOD: Psychiatric symptoms were assessed and average estrogen and progesterone levels from four consecutive weekly blood samples were measured in 22 female inpatients with schizophrenia who were also administered a neuropsychological battery. RESULTS: There were strong positive correlations between average estrogen level and cognitive function, especially measures of global cognitive function, verbal and spatial declarative memory, and perceptual-motor speed. Correlations of hormone levels with psychiatric symptoms were nonsignificant. CONCLUSIONS: Higher estrogen levels in female patients with schizophrenia are associated with better cognitive ability. These results may have implications for potential treatment of cognitive dysfunction with adjunctive estrogen in female patients with schizophrenia.

This article has been cited by other articles:

				J. S. Brown Jr Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia Schizophr Bull, January 31, 2008; (2008) sbm147v1. [Abstract] [Full Text] [PDF]

				N. Bergemann, P. Parzer, S. Jaggy, B. Auler, C. Mundt, and S. Maier-Braunleder Estrogen and Comprehension of Metaphoric Speech in Women Suffering From Schizophrenia: Results of a Double-Blind, Placebo-Controlled Trial Schizophr Bull, December 21, 2007; (2007) sbm138v1. [Abstract] [Full Text] [PDF]

				J. Jaeger, C. Tatsuoka, S. M. Berns, and F. Varadi Distinguishing Neurocognitive Functions in Schizophrenia Using Partially Ordered Classification Models Schizophr Bull, October 1, 2006; 32(4): 679 - 691. [Abstract] [Full Text] [PDF]

				R. Halari, R. Mehrotra, T. Sharma, and V. Kumari Does Self-perceived Mood Predict More Variance in Cognitive Performance Than Clinician-Rated Symptoms in Schizophrenia? Schizophr Bull, October 1, 2006; 32(4): 751 - 757. [Abstract] [Full Text] [PDF]

				R. Halari, V. Kumari, R. Mehrotra, M. Wheeler, M. Hines, and T. Sharma The Relationship of Sex Hormones and Cortisol with Cognitive functioning in Schizophrenia J Psychopharmacol, September 1, 2004; 18(3): 366 - 374. [Abstract] [PDF]

				J. Wong, M. V. Seeman, and H. Shapiro Case Report: Raloxifene in Postmenopausal Women With Psychosis: Preliminary Findings Am J Geriatr Psychiatry, December 1, 2003; 11(6): 697 - 698. [Full Text] [PDF]

				M. L. SHUER Neuropsychiatric Testing and the Menstrual Cycle Am J Psychiatry, April 1, 2002; 159(4): 679 - 680. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us